Home/Filings/4/0001144204-19-044703
4//SEC Filing

Hayward James A 4

Accession 0001144204-19-044703

CIK 0000744452other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:01 PM ET

Size

7.3 KB

Accession

0001144204-19-044703

Insider Transaction Report

Form 4
Period: 2019-09-12
Hayward James A
DirectorChairman, CEO and President10% Owner
Transactions
  • Exercise of In-Money

    Secured Convertible Note

    2019-09-121,585,3130 total
    Exercise: $0.54From: 2018-08-31Exp: 2021-11-28Common Stock (2,935,764 underlying)
  • Exercise of In-Money

    Common Stock

    2019-09-12$0.54/sh+2,935,764$1,585,3135,367,435 total
Footnotes (1)
  • [F1]The shares were issued as a result of the conversion of $1,585,313 of secured convertible notes that were originally issued on August 31, 2019 and November 30, 2019 and represent the outstanding principal and interest of such secured convertible notes.

Issuer

APPLIED DNA SCIENCES INC

CIK 0000744452

Entity typeother

Related Parties

1
  • filerCIK 0001357784

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 4:01 PM ET
Size
7.3 KB